CD8A and neoplasm: In mouse models of syngeneic tumors, targeted elimination of folate receptor-positive (FR+) TAMs within the tumor microenvironment (TME) using chimeric antigen receptor (CAR)-T cells leads to an increase in pro-inflammatory monocytes, recruitment of endogenous tumor-specific CD8+ T cells, a deceleration in tumor growth, and an extension of overall survival.